The feedback I received from brokers attending the biotech showcase last month wasn't very enthusiastic about RH's marketing skills.
Technicians have difficulty changing styles of pitch and dumbing it down for brokers/investors to understand.
If the science is truly moving in the right direction, Richard needs to recognise he needs help to better deliver the PYC message more effectively.
All shareholders will be demanding forward momentum in the share price, if those results are shaping up very positive.
In my opinion, the recent accumulation buying looks concentrated with one broker, so it is not Perth brokers getting generally interested in the PYC story - yet
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.25 |
Change
-0.055(4.23%) |
Mkt cap ! $726.1M | |||
| Open | High | Low | Value | Volume |
| $1.26 | $1.26 | $1.24 | $173.1K | 139.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 33352 | $1.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.30 | 7691 | 1 |
View Market Depth
| Last trade - 16.10pm 07/08/2025 (20 minute delay) ? |
| PYC (ASX) Chart |